BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37787304)

  • 1. Leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.
    Venugopalan RK; Singh N; Anthony ML; Kunnumbrath A; Gupta AK; Nath UK; Chowdhury N; Chandra H
    J Cancer Res Ther; 2023; 19(5):1335-1339. PubMed ID: 37787304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
    Cui W; Zhang D; Cunningham MT; Tilzer L
    Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
    Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
    J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-associated immunophenotypes subdivided in "categories of specificity" improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia.
    Rossi G; Giambra V; Minervini MM; De Waure C; Mancinelli S; Ciavarella M; Sinisi NP; Scalzulli PR; Carella AM; Cascavilla N
    Cytometry B Clin Cytom; 2020 May; 98(3):216-225. PubMed ID: 31697027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients.
    Gupta DG; Varma N; Naseem S; Sachdeva MUS; Bose P; Binota J; Kumar A; Gupta M; Rana P; Sonam P; Malhotra P; Trehan A; Khadwal A; Varma S
    Turk J Haematol; 2022 Feb; 39(1):1-12. PubMed ID: 34617433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic characterization of acute leukemias in Bahia, Brazil.
    Santos MMD; Santos ASD; Santos HHM; Santos LDS; Nascimento RJM; Torres AJL
    Einstein (Sao Paulo); 2023; 21():eAO0117. PubMed ID: 36629681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients.
    Jalal SD; Al-Allawi NAS; Al Doski AAS
    Int J Lab Hematol; 2017 Dec; 39(6):625-632. PubMed ID: 28722319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
    Abdulateef NA; Ismail MM; Aljedani H
    Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.
    Juárez-Avendaño G; Luna-Silva NC; Chargoy-Vivaldo E; Juárez-Martínez LA; Martínez-Rangel MN; Zárate-Ortiz N; Martínez-Valencia E; López-Martínez B; Pelayo R; Balandrán JC
    Technol Cancer Res Treat; 2020; 19():1533033820928436. PubMed ID: 32608319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
    Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
    J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic patterns of childhood acute leukemias in Indonesia.
    Supriyadi E; Widjajanto PH; Veerman AJ; Purwanto I; Nency YM; Gunawan S; Nafianti S; Purnomosari D; Intansari US; Westra G; Cloos J
    Asian Pac J Cancer Prev; 2011; 12(12):3381-7. PubMed ID: 22471485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
    Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
    J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.
    Seegmiller AC; Kroft SH; Karandikar NJ; McKenna RW
    Am J Clin Pathol; 2009 Dec; 132(6):940-9. PubMed ID: 19926587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
    Cheng J; Klairmont MM; Choi JK
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
    Peters JM; Ansari MQ
    Arch Pathol Lab Med; 2011 Jan; 135(1):44-54. PubMed ID: 21204710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis].
    Kern W; Haferlach T
    Med Klin (Munich); 2005 Jan; 100(1):54-9. PubMed ID: 15654545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.